Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock.

Sordi R, Chiazza F, Collotta D, Migliaretti G, Colas RA, Vulliamy P, Brohi K, Dalli J, Collino M, Thiemermann C.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003407. [Epub ahead of print]

PMID:
31188196
2.

Lipid mediators in platelet concentrate and extracellular vesicles: Molecular mechanisms from membrane glycerophospholipids to bioactive molecules.

Valkonen S, Holopainen M, Colas RA, Impola U, Dalli J, Käkelä R, Siljander PR, Laitinen S.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Aug;1864(8):1168-1182. doi: 10.1016/j.bbalip.2019.03.011. Epub 2019 Apr 10.

PMID:
30980920
3.

15-Epi-LXA4 and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture.

Dakin SG, Colas RA, Newton J, Gwilym S, Jones N, Reid HAB, Wood S, Appleton L, Wheway K, Watkins B, Dalli J, Carr AJ.

FASEB J. 2019 Mar 27:fj201900196R. doi: 10.1096/fj.201900196R. [Epub ahead of print]

4.

Leukocytes from obese individuals exhibit an impaired SPM signature.

López-Vicario C, Titos E, Walker ME, Alcaraz-Quiles J, Casulleras M, Durán-Güell M, Flores-Costa R, Pérez-Romero N, Forné M, Dalli J, Clària J.

FASEB J. 2019 Jun;33(6):7072-7083. doi: 10.1096/fj.201802587R. Epub 2019 Mar 6.

5.

Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA.

Tungen JE, Gerstmann L, Vik A, De Matteis R, Colas RA, Dalli J, Chiang N, Serhan CN, Kalesse M, Hansen TV.

Chemistry. 2019 Jan 28;25(6):1476-1480. doi: 10.1002/chem.201806029. Epub 2018 Dec 20.

PMID:
30511787
6.

n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis.

Frigerio F, Pasqualini G, Craparotta I, Marchini S, van Vliet EA, Foerch P, Vandenplas C, Leclercq K, Aronica E, Porcu L, Pistorius K, Colas RA, Hansen TV, Perretti M, Kaminski RM, Dalli J, Vezzani A.

Brain. 2018 Nov 1;141(11):3130-3143. doi: 10.1093/brain/awy247.

7.

PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function.

Pistorius K, Souza PR, De Matteis R, Austin-Williams S, Primdahl KG, Vik A, Mazzacuva F, Colas RA, Marques RM, Hansen TV, Dalli J.

Cell Chem Biol. 2018 Jun 21;25(6):749-760.e9. doi: 10.1016/j.chembiol.2018.04.017. Epub 2018 May 24.

8.

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.

Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, Forteza MJ, Jiang X, Andonova T, Walker ME, Dalli J, Arnardottir H, Gisterå A, Thul S, Wheelock CE, Paulsson-Berne G, Ketelhuth DFJ, Hansson GK, Bäck M.

Circulation. 2018 Oct 16;138(16):1693-1705. doi: 10.1161/CIRCULATIONAHA.117.032801.

9.

Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology.

Dalli J, Serhan CN.

Br J Pharmacol. 2019 Apr;176(8):1024-1037. doi: 10.1111/bph.14336. Epub 2018 Jun 3. Review.

10.

Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.

Motwani MP, Colas RA, George MJ, Flint JD, Dalli J, Richard-Loendt A, De Maeyer RP, Serhan CN, Gilroy DW.

JCI Insight. 2018 Mar 22;3(6). pii: 94463. doi: 10.1172/jci.insight.94463.

11.

New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses.

Chiang N, Riley IR, Dalli J, Rodriguez AR, Spur BW, Serhan CN.

FASEB J. 2018 Jul;32(7):4043-4052. doi: 10.1096/fj.201701493R. Epub 2018 Feb 28.

PMID:
29490167
12.

A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.

Mai NT, Dobbs N, Phu NH, Colas RA, Thao LT, Thuong NT, Nghia HD, Hanh NH, Hang NT, Heemskerk AD, Day JN, Ly L, Thu DD, Merson L, Kestelyn E, Wolbers M, Geskus R, Summers D, Chau NV, Dalli J, Thwaites GE.

Elife. 2018 Feb 27;7. pii: e33478. doi: 10.7554/eLife.33478.

13.

Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis.

Chen J, Hamers AJP, Finsterbusch M, Massimo G, Zafar M, Corder R, Colas RA, Dalli J, Thiemermann C, Ahluwalia A.

FASEB J. 2018 Jul;32(7):3816-3831. doi: 10.1096/fj.201701303R. Epub 2018 Feb 20.

PMID:
29465314
14.

Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease.

Colas RA, Souza PR, Walker ME, Burton M, Zasłona Z, Curtis AM, Marques RM, Dalli J.

Circ Res. 2018 Mar 16;122(6):855-863. doi: 10.1161/CIRCRESAHA.117.312472. Epub 2018 Feb 5.

15.

Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis.

Dalli J, Colas RA, Walker ME, Serhan CN.

Methods Mol Biol. 2018;1730:59-72. doi: 10.1007/978-1-4939-7592-1_4.

PMID:
29363065
16.

Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.

Colas RA, Ashton AW, Mukherjee S, Dalli J, Akide-Ndunge OB, Huang H, Desruisseaux MS, Guan F, Jelicks LA, Matos Dos Santos F, Nagajyothi J, Zingman MA, Reyes J, Weiss LM, Serhan CN, Tanowitz HB.

Infect Immun. 2018 Mar 22;86(4). pii: e00688-17. doi: 10.1128/IAI.00688-17. Print 2018 Apr.

17.

Resolvins suppress tumor growth and enhance cancer therapy.

Sulciner ML, Serhan CN, Gilligan MM, Mudge DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli J, Greene ER, Gus-Brautbar Y, Piwowarski J, Mammoto T, Zurakowski D, Perretti M, Sukhatme VP, Kaipainen A, Kieran MW, Huang S, Panigrahy D.

J Exp Med. 2018 Jan 2;215(1):115-140. doi: 10.1084/jem.20170681. Epub 2017 Nov 30.

18.

Pro-Resolving Mediators in Regulating and Conferring Macrophage Function.

Dalli J, Serhan CN.

Front Immunol. 2017 Nov 1;8:1400. doi: 10.3389/fimmu.2017.01400. eCollection 2017. Review.

19.

Immunoresolvents signaling molecules at intersection between the brain and immune system.

Dalli J, Serhan CN.

Curr Opin Immunol. 2018 Feb;50:48-54. doi: 10.1016/j.coi.2017.10.007. Epub 2017 Nov 16. Review.

20.

Prolonged immune alteration following resolution of acute inflammation in humans.

Motwani MP, Newson J, Kwong S, Richard-Loendt A, Colas R, Dalli J, Gilroy DW.

PLoS One. 2017 Oct 26;12(10):e0186964. doi: 10.1371/journal.pone.0186964. eCollection 2017.

21.

Microscale arrays for the profiling of start and stop signals coordinating human-neutrophil swarming.

Reátegui E, Jalali F, Khankhel AH, Wong E, Cho H, Lee J, Serhan CN, Dalli J, Elliott H, Irimia D.

Nat Biomed Eng. 2017;1. pii: 0094. doi: 10.1038/s41551-017-0094. Epub 2017 Jun 30.

22.

Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA.

Primdahl KG, Tungen JE, De Souza PRS, Colas RA, Dalli J, Hansen TV, Vik A.

Org Biomol Chem. 2017 Oct 18;15(40):8606-8613. doi: 10.1039/c7ob02113e.

PMID:
28980694
23.

Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy.

Dakin SG, Ly L, Colas RA, Oppermann U, Wheway K, Watkins B, Dalli J, Carr AJ.

Sci Rep. 2017 Sep 8;7(1):11009. doi: 10.1038/s41598-017-11188-y.

24.

Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease.

China L, Maini A, Skene SS, Shabir Z, Sylvestre Y, Colas RA, Ly L, Becares Salles N, Belloti V, Dalli J, Gilroy DW, O'Brien A.

Clin Gastroenterol Hepatol. 2018 May;16(5):738-747.e7. doi: 10.1016/j.cgh.2017.08.027. Epub 2017 Aug 30.

25.

New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.

Serhan CN, Chiang N, Dalli J.

Mol Aspects Med. 2018 Dec;64:1-17. doi: 10.1016/j.mam.2017.08.002. Epub 2017 Sep 1. Review.

PMID:
28802833
26.

The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions.

Hansen TV, Dalli J, Serhan CN.

Prostaglandins Other Lipid Mediat. 2017 Nov;133:103-110. doi: 10.1016/j.prostaglandins.2017.06.003. Epub 2017 Jun 7. Review.

27.

13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis.

Walker ME, Souza PR, Colas RA, Dalli J.

FASEB J. 2017 Aug;31(8):3636-3648. doi: 10.1096/fj.201700268. Epub 2017 May 2.

28.

Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid.

Vik A, Dalli J, Hansen TV.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2259-2266. doi: 10.1016/j.bmcl.2017.03.079. Epub 2017 Mar 31. Review.

PMID:
28408222
29.

Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide.

Perretti M, Di Filippo C, D'Amico M, Dalli J.

PLoS One. 2017 Apr 13;12(4):e0175786. doi: 10.1371/journal.pone.0175786. eCollection 2017.

30.

Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections?

Dalli J.

Mol Aspects Med. 2017 Dec;58:12-20. doi: 10.1016/j.mam.2017.03.007. Epub 2017 Apr 5. Review.

31.

Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection.

Gobbetti T, Dalli J, Colas RA, Federici Canova D, Aursnes M, Bonnet D, Alric L, Vergnolle N, Deraison C, Hansen TV, Serhan CN, Perretti M.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3963-3968. doi: 10.1073/pnas.1617290114. Epub 2017 Mar 29.

32.

NLRP3 Inflammasome Deficiency Protects against Microbial Sepsis via Increased Lipoxin B4 Synthesis.

Lee S, Nakahira K, Dalli J, Siempos II, Norris PC, Colas RA, Moon JS, Shinohara M, Hisata S, Howrylak JA, Suh GY, Ryter SW, Serhan CN, Choi AMK.

Am J Respir Crit Care Med. 2017 Sep 15;196(6):713-726. doi: 10.1164/rccm.201604-0892OC.

33.

Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution.

Dalli J, Colas RA, Arnardottir H, Serhan CN.

Immunity. 2017 Jan 17;46(1):92-105. doi: 10.1016/j.immuni.2016.12.009. Epub 2017 Jan 5.

34.

Immune resolution mechanisms in inflammatory arthritis.

Perretti M, Cooper D, Dalli J, Norling LV.

Nat Rev Rheumatol. 2017 Feb;13(2):87-99. doi: 10.1038/nrrheum.2016.193. Epub 2017 Jan 5. Review.

PMID:
28053331
35.

Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.

Norling LV, Ly L, Dalli J.

Curr Opin Clin Nutr Metab Care. 2017 Mar;20(2):145-152. doi: 10.1097/MCO.0000000000000353. Review.

36.

Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes.

Freire MO, Dalli J, Serhan CN, Van Dyke TE.

J Immunol. 2017 Jan 15;198(2):718-728. doi: 10.4049/jimmunol.1601543. Epub 2016 Dec 19.

37.

Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans.

Rathod KS, Kapil V, Velmurugan S, Khambata RS, Siddique U, Khan S, Van Eijl S, Gee LC, Bansal J, Pitrola K, Shaw C, D'Acquisto F, Colas RA, Marelli-Berg F, Dalli J, Ahluwalia A.

J Clin Invest. 2017 Jan 3;127(1):169-182. doi: 10.1172/JCI89429. Epub 2016 Nov 28.

38.

Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation.

Colas RA, Dalli J, Chiang N, Vlasakov I, Sanger JM, Riley IR, Serhan CN.

J Immunol. 2016 Dec 1;197(11):4444-4452. Epub 2016 Oct 31.

39.

Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages.

Dalli J, Vlasakov I, Riley IR, Rodriguez AR, Spur BW, Petasis NA, Chiang N, Serhan CN.

Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12232-12237. Epub 2016 Oct 6.

40.

Synthesis of 13(R)-Hydroxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins.

Primdahl KG, Aursnes M, Walker ME, Colas RA, Serhan CN, Dalli J, Hansen TV, Vik A.

J Nat Prod. 2016 Oct 28;79(10):2693-2702. Epub 2016 Oct 5.

41.

Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue.

Titos E, Rius B, López-Vicario C, Alcaraz-Quiles J, García-Alonso V, Lopategi A, Dalli J, Lozano JJ, Arroyo V, Delgado S, Serhan CN, Clària J.

J Immunol. 2016 Oct 15;197(8):3360-3370. Epub 2016 Sep 19.

42.

Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes.

Dalli J, Colas RA, Quintana C, Barragan-Bradford D, Hurwitz S, Levy BD, Choi AM, Serhan CN, Baron RM.

Crit Care Med. 2017 Jan;45(1):58-68.

43.

Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.

Chiurchiù V, Leuti A, Dalli J, Jacobsson A, Battistini L, Maccarrone M, Serhan CN.

Sci Transl Med. 2016 Aug 24;8(353):353ra111. doi: 10.1126/scitranslmed.aaf7483.

44.

Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation.

Arnardottir HH, Dalli J, Norling LV, Colas RA, Perretti M, Serhan CN.

J Immunol. 2016 Sep 15;197(6):2362-8. doi: 10.4049/jimmunol.1502268. Epub 2016 Aug 17.

45.
46.

Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators.

Tsoyi K, Hall SR, Dalli J, Colas RA, Ghanta S, Ith B, Coronata A, Fredenburgh LE, Baron RM, Choi AM, Serhan CN, Liu X, Perrella MA.

Crit Care Med. 2016 Dec;44(12):e1236-e1245.

47.

Macrophage Proresolving Mediators-the When and Where.

Dalli J, Serhan C.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.MCHD-0001-2014. Review.

48.

Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Protective for Injured Epithelia.

Colby JK, Abdulnour RE, Sham HP, Dalli J, Colas RA, Winkler JW, Hellmann J, Wong B, Cui Y, El-Chemaly S, Petasis NA, Spite M, Serhan CN, Levy BD.

Am J Pathol. 2016 Jul;186(7):1801-1813. doi: 10.1016/j.ajpath.2016.03.011. Epub 2016 May 10.

49.

Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis.

Norling LV, Headland SE, Dalli J, Arnardottir HH, Haworth O, Jones HR, Irimia D, Serhan CN, Perretti M.

JCI Insight. 2016 Apr 21;1(5):e85922. doi: 10.1172/jci.insight.85922.

50.

Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.

Elajami TK, Colas RA, Dalli J, Chiang N, Serhan CN, Welty FK.

FASEB J. 2016 Aug;30(8):2792-801. doi: 10.1096/fj.201500155R. Epub 2016 Apr 27.

Supplemental Content

Support Center